RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Advertising, Labeling & Promotion

In Focus: Advertising, Labeling & Promotion

Posted 01 November 2009

A two-day FDA public meeting on social media… Issuance of two FDA guidance documents relating to Good Reprint Practices and presentation of risk information in prescription drug and medical device promotion… A legal challenge to FDA's policies on off-label promotion… An increase in FDA enforcement letters relating to product promotion, with more likely to come… Yes, advertising and promotion remains a hot regulatory topic, with more activity to come.

 

© 2022 Regulatory Affairs Professionals Society.